BioCryst Pharmaceuticals, Inc.
NASDAQ: BCRX
$3.97
-$0.03 (-0.8%)
Closing price August 7, 2020
The include BioCryst Pharmaceuticals, Exxon Mobil, Fiat Chrysler Automobiles, Hewlett Packard Enterprise, IAMGOLD, Mallinckrodt and Rockwell Collins.
2 years ago
Last Updated: 4 months ago
BioCryst Pharmaceuticals saw its shares make a handy gain on early Tuesday after it released the final results from its mid-stage clinical trial in hereditary angioedema.
2 years ago
Last Updated: 6 months ago
The top analyst upgrades, downgrades and initiations seen on Thursday include BioCryst Pharmaceuticals, Cisco Systems, Groupon, SunPower, Tesla and Wells Fargo.
3 years ago
Last Updated: 6 months ago
FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in 2016 or 2017.
4 years ago
Last Updated: 6 months ago
These biotech companies 24/7 Wall St. has picked stood out from the rest with big moves over the course of last week.
4 years ago
Last Updated: 6 months ago
BioCryst Pharmaceuticals shares were crushed after it announced results from OPuS-2 for the treatment of hereditary angioedema attacks.
4 years ago
Last Updated: 6 months ago
For the third straight week, insider selling has been nonexistent, while the insider buyers have taken advantage of the market sell-off.
4 years ago
Last Updated: 6 months ago
Jefferies is out with its first group of growth stocks to buy this year, and the list has not only some timely picks, but companies that have been knocked to levels that are providing some of the...
4 years ago
Last Updated: 6 months ago
The top analyst calls for Wednesday, January 6, 2016, include Bluebird Bio, Check Point Software, Comcast, Eli Lilly, Hyatt Hotels, Lockheed Martin and Rite Aid.
4 years ago
Last Updated: 6 months ago
Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a great amount of risk...
4 years ago
Last Updated: 6 months ago
24/7 Wall St. has collected several big FDA decisions coming up in the month of November.
4 years ago
Last Updated: 6 months ago
Friday's top analyst upgrades, downgrades and initiations include AT&T, BioCryst Pharmaceuticals, Eli Lilly, Facebook, Flextronics, Gap and Tesla Motors.
4 years ago
Last Updated: 4 years ago
The most recent analyst call by Merrill Lynch for BioCryst Pharmaceuticals may be very misunderstood for what it is.
5 years ago
Last Updated: 3 months ago
The health care sector and biotech in particular have been on fire so far in 2015, but some biotech stocks in the group just are not carrying their weight.
5 years ago
Last Updated: 5 years ago
Within the past week, two Ebola-related companies are showing renewed optimism for their positions, whether it is securing a contract or raising capital.
5 years ago
Last Updated: 3 months ago